Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF) now has two licensed treatments available. Pirfenidone was the first drug to be licensed and approved for use, followed by nintedanib. We set out our real world experience with these agents in terms of their adverse events profile outside the restrictions of a cli...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Med
Hlavní autoři: Hughes, Gareth, Toellner, Hannah, Morris, Helen, Leonard, Colm, Chaudhuri, Nazia
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2016
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5039481/
https://ncbi.nlm.nih.gov/pubmed/27598213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm5090078
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky